Skip to main content

Nonhormonal Treatments for Insomnia

  • Chapter
Book cover Sleep Disorders in Women

Part of the book series: Current Clinical Neurology ((CCNEU))

  • 759 Accesses

Abstract

Insomnia is a common and growing complaint; 54% of adults report experiencing at least one symptom of insomnia a few nights a week, and 33% of adults report experiencing at least one symptom every night, according to the National Sleep Foundation’s 2005 Sleep in America poll (1) Of those adults experiencing at least one symptom of insomnia a few nights a week, women comprise 57%, whereas men comprise 51% (1), although women are 1.5 times more likely than men to experience insomnia when using full diagnostic criteria (2.)

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. National Sleep Foundation. Sleep in America Poll. http://www.sleepfoundation.org/content/hottopics/2005summaryoffindings.pdf, 2005.

  2. Doghramji, P.P., Detection of insomnia in primary care. J Clin Psychiatry, 2001;62(Suppl 10):18–26.

    PubMed  Google Scholar 

  3. Anonymous, Sleep disorders. In: Diagnostic and Statistical Manual of Mental Disorders, Washington DC: American Psychiatric Publishing. 2000:597–662.

    Google Scholar 

  4. American Academy of Sleep Medicine, The International Classification of Sleep Disorders, Revised Diagnostic and Coding Manual. 2nd ed. Chicago, IL: Author; 2005.

    Google Scholar 

  5. World Health Organization, F50-F59: Behavioural syndromes associated with psychological disturbances and physical factors. The International Statistical Classification of Diseases and Related Health Problems, 10th revision. 1992:174–197.

    Google Scholar 

  6. McClusky, H.Y., J.B. Milby, P.K. Scoitzer, V. Williams, and V. Wooten, Efficacy of behavioral versus triazolam treatment in persistent sleep-onset insomnia. Am J Psychiatry, 1991;148(sn1):121–126.

    PubMed  CAS  Google Scholar 

  7. Morin, C.M., C. Colecchi, J. Stone, R. Sood, and D. Brink, Behavioral and pharmacological therapies for late-life insomnia: a randomized controlled trial. JAMA, 1999;281(11):991–999.

    Article  PubMed  CAS  Google Scholar 

  8. Smith, M.T., M.L. Perlis, A. Park, et al., Comparative meta-analysis of pharmacotherapy and behavior therapy for persistent insomnia. Am J Psychiatry, 2002;159(1):5–11.

    Article  PubMed  Google Scholar 

  9. Spielman, A.J., L.S. Caruso, and P.B. Glovinsky, A behavioral perspective on insomnia treatment. Psychiatr Clin North Am, 1987;10(4):541–553.

    PubMed  CAS  Google Scholar 

  10. Bootzin, R.R. and Nicassio, P.M., Behavioral treatments for insomnia. In: Progress in Behavior Modification (ei]M._Hersen, R. Eissler, P. Miller, eds.). 1978:1–45.

    Google Scholar 

  11. Roehrs, T., E. Hollebeek, C. Drake, and T. Roth, Substance use for insomnia in metropolitan Detroit. J Psychosom Res, 2002;53(1):571–576.

    Article  PubMed  Google Scholar 

  12. Weiler, J.M., J.R. Bloomfield, G.G. Woodworth, et al., Effects of fexofenadine, diphenhydramine, and alcohol on driving performance. A randomized, placebo-controlled trial in the Iowa driving simulator. Ann Intern Med, 2000;132(5):354–363.

    PubMed  CAS  Google Scholar 

  13. Hedner, J., R. Yaeche, G. Emilien, I. Farr, and E. Salinas, Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. Int J Geriatr Psychiatry, 2000;15(8):704–712.

    Article  PubMed  CAS  Google Scholar 

  14. Israel, A.G. and J.A. Kramer, Safety of zaleplon in the treatment of insomnia. Ann Pharmacother, 2002;36(5):852–859.

    Article  PubMed  CAS  Google Scholar 

  15. Krystal, A.D., J.K. Walsh, E. Laska, et al., Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep, 2003;26(7):793–799.

    PubMed  Google Scholar 

  16. Mendelson, W.B., T. Roth, S. Cassella, et al., The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev, 2004;8(1):7–17.

    Article  PubMed  Google Scholar 

  17. Saletu-Zyhlarz, G., P. Anderer, N. Brandstatter, et al., Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder. Neuropsychobiology, 2000;41(3):139–148.

    Article  PubMed  CAS  Google Scholar 

  18. Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone. Prog Neuropsychopharmacol Biol Psychiatry, 2002;26(2):249–260.

    Article  PubMed  CAS  Google Scholar 

  19. Saletu-Zyhlarz, G.M., M.H. Abu-Baker, P. Anderer, et al., Insomnia related to dysthymia: polysomnographic and psychometric comparison with normal controls and acute therapeutic trials with trazodone. Neuropsychobiology, 2001;44(3):139–149.

    Article  PubMed  CAS  Google Scholar 

  20. Montgomery, I., I. Oswald, K. Morgan, and K. Adam, Trazodone enhances sleep in subjective quality but not in objective duration. Br J Clin Pharmacol, 1983;16(2):139–144.

    PubMed  CAS  Google Scholar 

  21. Zhdanova, I.V., R.J. Wortman, M.M. Regan, J.A. Taylor, J.P. Shi, and O.U. Leclair, Melatonin treatment for age-related insomnia. J Clin Endocrinol Metab, 2001;86(10):4727–4730.

    Article  PubMed  CAS  Google Scholar 

  22. Smits, M.G., E.E. Nagtegaal, J. van der Heijden, A.M. Coenen, and G.A. Kerkhof, Melatonin for chronic sleep onset insomnia in children: a randomized placebo-controlled trial. J Child Neurol, 2001;16(2):86–92.

    Article  PubMed  CAS  Google Scholar 

  23. Almeida Montes, L.G., H.P. Ontiveros Uribe, J. Cortes Sotres, and G. Heinze Martin, Treatment of primary insomnia with melatonin: a double-blind, placebo-controlled, crossover study. J Psychiatry Neurosci, 2003;28(3):191–196.

    PubMed  Google Scholar 

  24. Arendt, J., Complex effects of melatonin. Therapie, 1998;53(5):479–488.

    PubMed  CAS  Google Scholar 

  25. Sack, R.L., A.J. Lewy, and R.J. Hughes, Use of melatonin for sleep and circadian rhythm disorders. Ann Med, 1998;30(1):115–121.

    PubMed  CAS  Google Scholar 

  26. Stone, B.M., C. Turner, S.L. Mills, and A.N. Nicholson, Hypnotic activity of melatonin. Sleep, 2000;23(5):663–669.

    PubMed  CAS  Google Scholar 

  27. Doghramji, P.P., Treatment of insomnia with zaleplon, a novel sleep medication. Int J Clin Pract, 2001;55(5):329–334.

    PubMed  CAS  Google Scholar 

  28. Donath, F., S. Quispe, K. Diefenbach, A. Maurer, I. Fietze, and I. Roots, Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry, 2000;33(2):47–53.

    Article  PubMed  CAS  Google Scholar 

  29. Dorn, M., (Efficacy and tolerability of Baldrian versus oxazepam in non-organic and non-psychiatric insomniacs: a randomised, double-blind, clinical, comparative study). Forsch Komplementarmed Klass Naturheilkd, 2000;7(2):79–84.

    Article  PubMed  CAS  Google Scholar 

  30. Fussel, A., A. Wolf, and A. Brattstrom, Effect of a fixed valerian-Hop extract combination (Ze 91019) on sleep polygraphy in patients with non-organic insomnia: a pilot study. Eur J Med Res, 2000;5(9):385–390.

    PubMed  CAS  Google Scholar 

  31. Ziegler, G., M. Ploch, A. Miettinen-Baumann, and W. Collett, Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia-a randomized, double-blind, comparative clinical study. Eur J Med Res, 2002;7(11):480–486.

    PubMed  CAS  Google Scholar 

  32. Poyares, D.R., C. Guilleminault, M.M. Ohayon, and S. Tufik, Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Prog Neuropsychopharmacol Biol Psychiatry, 2002;26(3):539–545.

    Article  PubMed  CAS  Google Scholar 

  33. Zammit, G., T. Roth, M. Erman, S. Sainati, S. Weigand, and J. Zhang, Polysomnography and outpatient study to determine the efficacy of Ramelten in adults with chronic insomnia. 2005;227.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press Inc., Totowa, NJ

About this chapter

Cite this chapter

Schuman, C.C. (2006). Nonhormonal Treatments for Insomnia. In: Attarian, H.P. (eds) Sleep Disorders in Women. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59745-115-4_9

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-115-4_9

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-592-7

  • Online ISBN: 978-1-59745-115-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics